Is ERGO.L undervalued or overvalued?
As of 2025-03-16, the Intrinsic Value of Ergomed PLC (ERGO.L) is 820.82 GBP. This ERGO.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1,346.00 GBP, the upside of Ergomed PLC is -39.00%. This means that ERGO.L is overvalued by 39.00%.
The range of the Intrinsic Value is 624.01 - 1,252.09 GBP
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 624.01 - 1,252.09 | 820.82 | -39.0% |
DCF (Growth 10y) | 906.99 - 1,809.81 | 1,191.98 | -11.4% |
DCF (EBITDA 5y) | 995.13 - 1,635.12 | 1,305.46 | -3.0% |
DCF (EBITDA 10y) | 1,216.79 - 2,079.98 | 1,613.30 | 19.9% |
Fair Value | 734.51 - 734.51 | 734.51 | -45.43% |
P/E | 846.16 - 1,238.81 | 1,065.43 | -20.8% |
EV/EBITDA | 608.23 - 1,204.28 | 853.44 | -36.6% |
EPV | 439.05 - 576.19 | 507.62 | -62.3% |
DDM - Stable | 233.92 - 659.14 | 446.53 | -66.8% |
DDM - Multi | 525.10 - 1,167.96 | 726.51 | -46.0% |
Market Cap (mil) | 687.33 |
Beta | 1.02 |
Outstanding shares (mil) | 0.51 |
Enterprise Value (mil) | 664.32 |
Market risk premium | 5.98% |
Cost of Equity | 9.40% |
Cost of Debt | 6.61% |
WACC | 9.39% |